Latest Stock Market News

“It just seems silly to me that the market for the last two-three years have been ignoring IT and that is partly the case I am building for the public sector stocks also because they have such clear order books, there is so much visibility, the government is committed to a capex cycle for defence, for railways.”

Rate this item

(1 Vote)

"The market now lacks direction and is moving up or down on a daily basis responding to news regarding crude price, FPI flows and speculation on what the Fed might do in the coming policy meeting. Nifty is likely to move in the 17,000-17,500 range in the short run," said VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services.

Rate this item

(1 Vote)

“Hindustan Unilever after the kind of correction it has seen looks good and definitely can be picked up at current level with a long term view in mind. ITC also can be picked up by long-term investors in spite of the fact that it has run up quite a bit.”

Share price of Zee Ent. rises as Nifty strengthens

Updated at : 2022-03-24 10:20:03

Rate this item

(1 Vote)

A total of 1,452,858 shares changed hands on the counter till 10:00AM (IST).

JSPL is the only company in our universe which offers strong volume growth, deleveraging and increase in share of captive raw materials, the brokerage said.

The Nifty Auto index was trading 0.18 per cent up at 10482.2.

Bond rout pushes cash back in to stocks

Updated at : 2022-03-24 09:20:04

Rate this item

(1 Vote)

Bond markets extended their retreat as investors braced for the Federal Reserve to take an even more aggressive approach to taming inflation. Two-year Treasury yields are up 76 basis points (bps) in March and 10-year yields are up almost 60 bps to 2.4154%, the highest since 2019.

The RBI has allowed SBI Mutual Fund and other entities in the SBI group to together hold up to 9.99 per cent stake in ICICI Bank.

Rate this item

(1 Vote)

NMDC has crossed 40 million tons of production volumes during March 2022 and is likely to post a strong 23% YoY growth in volumes in FY2022E, said Kotak Institutional Equities.

Aster DM Healthcare key Products/Revenue Segments include Hospital Services, Other Operating Revenue, Pharmaceuticals, Other Services, Consultancy Income for the year ending 31-Mar-2021.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.